- Home
- EXK vs ATRC Comparison
EXK vs ATRC Comparison
Compare EXK & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXK
- ATRC
- Stock Information
- Founded
- EXK 1981
- ATRC 2000
- Country
- EXK Canada
- ATRC United States
- Employees
- EXK N/A
- ATRC N/A
- Industry
- EXK Precious Metals
- ATRC Medical/Dental Instruments
- Sector
- EXK Basic Materials
- ATRC Health Care
- Exchange
- EXK Nasdaq
- ATRC Nasdaq
- Market Cap
- EXK 1.5B
- ATRC 1.6B
- IPO Year
- EXK N/A
- ATRC 2005
- Fundamental
- Price
- EXK $5.76
- ATRC $35.84
- Analyst Decision
- EXK Strong Buy
- ATRC Strong Buy
- Analyst Count
- EXK 3
- ATRC 10
- Target Price
- EXK $8.33
- ATRC $49.60
- AVG Volume (30 Days)
- EXK 8.2M
- ATRC 709.9K
- Earning Date
- EXK 08-13-2025
- ATRC 07-29-2025
- Dividend Yield
- EXK N/A
- ATRC N/A
- EPS Growth
- EXK N/A
- ATRC N/A
- EPS
- EXK N/A
- ATRC N/A
- Revenue
- EXK $217,412,000.00
- ATRC $499,946,000.00
- Revenue This Year
- EXK $77.92
- ATRC $14.63
- Revenue Next Year
- EXK $68.80
- ATRC $12.62
- P/E Ratio
- EXK N/A
- ATRC N/A
- Revenue Growth
- EXK 1.72
- ATRC 16.28
- 52 Week Low
- EXK $2.46
- ATRC $20.70
- 52 Week High
- EXK $6.04
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- EXK 62.65
- ATRC 60.12
- Support Level
- EXK $5.19
- ATRC $34.92
- Resistance Level
- EXK $5.32
- ATRC $37.80
- Average True Range (ATR)
- EXK 0.24
- ATRC 1.64
- MACD
- EXK -0.00
- ATRC 0.29
- Stochastic Oscillator
- EXK 92.86
- ATRC 71.55
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.